Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study
Top Cited Papers
Open Access
- 31 March 2021
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 57 (4), 2003690
- https://doi.org/10.1183/13993003.03690-2020
Abstract
Background: The infectious coronavirus disease 2019 (COVID-19) pandemic is an ongoing global healthcare challenge. Up to one-third of hospitalised patients develop severe pulmonary complications and acute respiratory distress syndrome. Pulmonary outcomes following COVID-19 are unknown. Methods: The Swiss COVID-19 lung study is a multicentre prospective cohort investigating pulmonary sequelae of COVID-19. We report on initial follow-up 4 months after mild/moderate or severe/critical COVID-19 according to the World Health Organization severity classification. Results: 113 COVID-19 survivors were included (mild/moderate n=47, severe/critical n=66). We confirmed several comorbidities as risk factors for severe/critical disease. Severe/critical disease was associated with impaired pulmonary function, i.e. diffusing capacity of the lung for carbon monoxide (D-LCO) % predicted, reduced 6-min walk distance (6MWD) and exercise-induced oxygen desaturation. After adjustment for potential confounding by age, sex and body mass index (BMI), patients after severe/critical COVID-19 had a D-LCO 20.9% pred (95% CI 12.4-29.4% pred, p=0.01) lower at follow-up. D-LCO % pred was the strongest independent factor associated with previous severe/critical disease when age, sex, BM1, 6MWD and minimal peripheral oxygen saturation at exercise were included in the multivariable model (adjusted odds ratio per 10% predicted 0.59, 95% CI 0. 37-0.87; p=0.01). Mosaic hypoattenuation on chest computed tomography at follow-up was significantly associated with previous severe/critical COVID-19 including adjustment for age and sex (adjusted OR 11.7, 95% CI 1.7-239; p=0.03). Conclusions: 4 months after severe acute respiratory syndrome coronavirus 2 infection, severe/critical COVID-19 was associated with significant functional and radiological abnormalities, potentially due to small-airway and lung parenchymal disease. A systematic follow-up for survivors needs to be evaluated to optimise care for patients recovering from COVID-19.Keywords
Funding Information
- Department for Research and Education, Inselspital
- Bern Center for Precision Medicine
- Johanna Dürmüller Foundation
- Lungenliga Bern
This publication has 39 references indexed in Scilit:
- Functional Disability 5 Years after Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2011
- The long‐term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health statusRespirology, 2010
- Radiology of Severe Acute Respiratory Syndrome (SARS)Journal of Thoracic Imaging, 2006
- The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of SurvivorsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2005
- Standardisation of the measurement of lung volumesEuropean Respiratory Journal, 2005
- Pulmonary pathology of severe acute respiratory syndrome in TorontoLaboratory Investigation, 2005
- The spectrum of pathological changes in severe acute respiratory syndrome (SARS)Histopathology, 2004
- Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)Journal of Clinical Pathology, 2004
- Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic CorrelatesEmerging Infectious Diseases, 2003
- ATS/ERS Statement on Respiratory Muscle TestingAmerican Journal of Respiratory and Critical Care Medicine, 2002